BNP Paribas Financial Markets
FBIO icon

BNP Paribas Financial Markets’s Fortress Biotech FBIO Stock Holding History

BNP Paribas Financial Markets’s Portfolio FBIO Stock Details FBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-2
Closed -$6 – 5978
2026
Q1 		$6 Hold
2
– – ﹤0.01% 5778
2025
Q4 		$7 Hold
2
– – ﹤0.01% 5699
2025
Q3 		$7 Sell
2
-376
-99% -$951 ﹤0.01% 5529
2025
Q2 		$703 Buy
378
+2
+0.5% +$3 ﹤0.01% 5188
2025
Q1 		$587 Hold
376
– – ﹤0.01% 5126
2024
Q4 		$761 Hold
376
– – ﹤0.01% 5119
2024
Q3 		$543 Hold
376
– – ﹤0.01% 3998
2024
Q2 		$643 Hold
376
– – ﹤0.01% 3889
2024
Q1 		$752 Buy
+376
New +$748 ﹤0.01% 3881
2023
Q4 		– Sell
-377
Closed -$1.64K – 4034
2023
Q3 		$1.64K Hold
377
– – ﹤0.01% 3720
2023
Q2 		$3.11K Hold
377
– – ﹤0.01% 3700
2023
Q1 		$4.63K Sell
377
-30
-7% -$357 ﹤0.01% 3587
2022
Q4 		$4K Hold
407
– – ﹤0.01% 3682
2022
Q3 		$5.25K Sell
407
-2,235
-85% -$33.5K ﹤0.01% 4247
2022
Q2 		$33.3K Buy
2,642
+2,198
+495% +$32.6K ﹤0.01% 3643
2022
Q1 		$9.06K Sell
444
-601
-58% -$16.5K ﹤0.01% 3817
2021
Q4 		$39.2K Buy
1,045
+214
+26% +$9.54K ﹤0.01% 3779
2021
Q3 		$40.1K Buy
831
+633
+320% +$30.9K ﹤0.01% 3562
2021
Q2 		$10.6K Sell
198
-383
-66% -$23.1K ﹤0.01% 3712
2021
Q1 		$30.8K Sell
581
-301
-34% -$17K ﹤0.01% 3701
2020
Q4 		$42K Sell
882
-116
-12% -$5.02K ﹤0.01% 3635
2020
Q3 		$60.5K Buy
998
+852
+584% +$43.4K ﹤0.01% 3384
2020
Q2 		$5.86K Buy
146
+133
+1,023% +$4.94K ﹤0.01% 3935
2020
Q1 		$382 Hold
13
– – ﹤0.01% 4156
2019
Q4 		$519 Sell
13
-297
-96% -$7.63K ﹤0.01% 4249
2019
Q3 		$6.55K Hold
310
– – ﹤0.01% 4231
2019
Q2 		$6.97K Sell
310
-234
-43% -$6.02K ﹤0.01% 4185
2019
Q1 		$14.5K Buy
544
+506
+1,332% +$13.3K ﹤0.01% 3970
2018
Q4 		$491 Sell
38
-35
-48% -$584 ﹤0.01% 4008
2018
Q3 		$1.75K Sell
73
-1
-1% -$32 ﹤0.01% 4279
2018
Q2 		$3.31K Sell
74
-381
-84% -$21.5K ﹤0.01% 4192
2018
Q1 		$31K Sell
455
-25
-5% -$1.58K ﹤0.01% 3782
2017
Q4 		$28.7K Buy
480
+245
+104% +$14.4K ﹤0.01% 3892
2017
Q3 		$15.6K Sell
235
-13
-5% -$876 ﹤0.01% 3713
2017
Q2 		$17.7K Buy
248
+234
+1,671% +$13.8K ﹤0.01% 3728
2017
Q1 		$770 Sell
14
-25
-64% -$1.12K ﹤0.01% 3752
2016
Q4 		$1.6K Sell
39
-115
-75% -$4.3K ﹤0.01% 3960
2016
Q3 		$6.88K Buy
154
+64
+71% +$2.72K ﹤0.01% 3317
2016
Q2 		$3.63K Buy
+90
New +$4.19K ﹤0.01% 3377
2014
Q4 		– Sell
-6
Closed -$183 – 2388
2014
Q3 		$183 Sell
6
-3
-33% -$80 ﹤0.01% 4047
2014
Q2 		$225 Buy
+9
New +$237 ﹤0.01% 3695
2014
Q1 		– Sell
-23
Closed -$907 – 3529
2013
Q4 		$907 Buy
+23
New +$888 ﹤0.01% 3849

Other funds holding FBIO

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
SAM
Shikiar Asset Management New York $396M AUM 41.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
HWM
HB Wealth Management Atlanta, Georgia $17.8B AUM 24.16% 1-Year Est. Return
KAS
Kestra Advisory Services Austin, Texas $31B AUM 28.39% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

BNP Paribas Financial Markets's FBIO Position: Q2 2026 in Review

BNP Paribas Financial Markets sold out of Fortress Biotech (FBIO) in Q2 2026, closing a stake of 2 shares — an estimated $6 sold.

BNP Paribas Financial Markets first reported a position in FBIO in Q4 2013 and held it in 42 quarters. The position peaked at $60.5K in Q3 2020. 38 funds tracked by Wall St. Rank hold FBIO as of Q2 2026.

  • BNP Paribas Financial Markets reported no remaining Fortress Biotech position as of Q2 2026 after selling out during the quarter.
  • BNP Paribas Financial Markets sold 2 Fortress Biotech shares in Q2 2026, an estimated $6.
  • BNP Paribas Financial Markets first reported a position in Fortress Biotech in Q4 2013 and held it in 42 quarters.
  • BNP Paribas Financial Markets's Fortress Biotech position peaked at $60.5K in Q3 2020.
  • 38 funds tracked by Wall St. Rank held Fortress Biotech as of Q2 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.